Kaiser Permanente
Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Being vaccinated against COVID-19 during pregnancy provides protection for the baby through its first several months of life, a Kaiser Permanente analysis finds. Protection was stronger against the delta variant than the more recent omicron variant.
Pregnant Kaiser Permanente patients were more likely to report intimate partner violence or living in unstable or unsafe situations during the first months of the COVID-19 pandemic, according to new research published in JAMA Network Open.
People who had bariatric surgery to address obesity and later became pregnant had less risk of poor outcomes such as preeclampsia or gestational diabetes, in comparison with similar pregnant patients who did not have the surgery.
A Kaiser Permanente analysis of prenatal exposure to the persistent environmental chemicals known as PFAS found suggestive evidence of an association with autism-related traits in children for just 1 of 8 PFAS chemicals studied.
California’s legalization of cannabis for adult-use may have reduced the stigma of using cannabis products during pregnancy and made them easier to obtain, according to new research from Kaiser Permanente investigators.
New Kaiser Permanente research suggests a national clinical guideline on evaluating infant fever may not be ideal in all health care settings.
Kelly Young-Wolff, PhD, MPH, a clinical psychologist and Kaiser Permanente Division of Research investigator who studies substance use among vulnerable populations, including pregnant women, was awarded the 2022 Young Professional Award by the American Public Health Association (APHA) Maternal and Child Health (MCH) Section.
Pregnant people may have increased risk of gestational diabetes if they have higher exposure to phenols, common chemicals used in food packaging and many consumer products, according to Kaiser Permanente research.
A new study led by Kaiser Permanente researchers provides reassurance about vaccinating infants whose mothers took biologic medications for an autoimmune disorder during pregnancy.
Kaiser Permanente researchers have identified several biological markers in the blood of pregnant people that are tied to an increased risk of developing gestational diabetes later in pregnancy.
